Fraser Nicola Marion 4
4 · INTELLIGENT BIO SOLUTIONS INC. · Filed Mar 20, 2026
Research Summary
AI-generated summary of this filing
Intelligent Bio Solutions (INBS) Director Fraser Marion Receives Award
What Happened
Fraser Nicola Marion, a director of Intelligent Bio Solutions Inc. (INBS), was granted 5,000 restricted shares of common stock on March 18, 2026. The shares were reported at $0.00 per share (total reported value $0) and were granted under the company's 2019 Long Term Incentive Plan. This transaction is an equity award (grant), not an open‑market purchase or sale.
Key Details
- Transaction date: March 18, 2026. Transaction type/code: Award/Grant (A).
- Shares granted: 5,000 restricted shares; reported price: $0.00; reported total value: $0.
- Vesting/forfeiture: Time‑based vesting after 12 months; shares are subject to forfeiture until vested (per filing).
- Reverse split note: All amounts are presented post a 1-for-10 reverse stock split effective Dec 15, 2025 (filing footnote).
- Shares owned after transaction: Not specified in the Form 4 filing.
- Filing timeliness: The Form 4 was filed on Mar 20, 2026 for a Mar 18, 2026 transaction; no late‑filing indication was reported.
Context
Restricted share grants are compensation awards and differ from purchases or sales — they generally reflect company compensation decisions rather than immediate insider buying/selling activity. These shares will not be freely tradable until they vest (12‑month time‑based vesting) and remain subject to forfeiture until that time. The filing shows amounts post-reverse split, so share counts reflect the reduced outstanding share base after the Dec 2025 1-for-10 reverse split.
Insider Transaction Report
- Award
Common Stock
[F2][F1]2026-03-18+5,000→ 5,000 total
Footnotes (2)
- [F1]On December 15, 2025, Intelligent Bio Solutions Inc. (the "Issuer") effected a 1-for-10 reverse stock split of the Issuer's common stock ("Common Stock"). The reverse stock split effected in December 2025, and prior reverse stock splits effected by the Issuer, resulted in a reduction in the number of shares held by the reporting person and proportional adjustments to the outstanding equity awards held by the reporting person. Accordingly, all amounts in this Form 4 are presented on a post-reverse split basis.
- [F2]On March 18, 2026, the Issuer granted the reporting person 5,000 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The awarded shares are subject to time-based vesting after 12 months and are subject to forfeiture until vested.